Clinical News

Clinical Status

<div class="articleContainer"><div class="articleWrapper"><div class="articleContent"><h1 class="text title">Vimpat lacosamide: Phase II started</h1><div class="byline">WIR Staff</div><div class="date"></div></div></div></div>

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

UCB began a U.S. and European Phase II trial to evaluate Vimpat lacosamide in patients. ......

Vimpat lacosamide: Phase II started

Featured Analysis

Articles by Category

Current Editions

Data Graphics

Distillery: Disruptive Innovation

Distillery

Hot Topics

Podcasts & Webcasts

Special Reports & Presentations

White Papers

Analysis

BCIQ

Company Profiles

Product Profiles

Target Profiles

Financial Dashboards

BCIQ Data

All Events

BioCentury Grand Rounds 2024

BioCentury Grand Rounds

The BioCentury-BayHelix China Healthcare Summit

BioCentury-BayHelix China Healthcare Summit

BioCentury-BIA Jefferies 2024

The BioCentury-BayHelix East-West BioPharma Summit

BioCentury-BayHelix East-West Summit

Bio€quity Europe

The BioCentury Show

Webinars - Upcoming & On-Demand

Events

My Workspace

Management

Analysts & Research Team

Scientific Advisory Board

About BioCentury

Contact Us

Forgot Password

Request a Trial

Request a Subscription

Sponsorship & Branding Inquiry 

Media Kit

Request BioCentury's BCIQ Brochure

Customer Resource Center

Career Opportunities

Contact

Home